Structural and functional diversity of paraoxonases

Several forms of a paraoxonase enzyme provide different degrees of protection against organophosphate chemicals.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Hyde, E.G. & Carmichael, W.W. Anatoxin-a (S), a naturally occurring organo-phosphate, is an irreversible active site-directed inhibitor of acetyl-cholinesterase (EC 3.1.1. 7). J. Biochem. Toxicol. 6, 195–201 (1991).

  2. 2

    La Du, B.N. Human serum paraoxonase/arylesterase. in Pharmacogenetics of Drug Metabolism (ed. Karlow, W.) 51–91 (Pergamon, New York, 1992).

  3. 3

    Davies, H.G. et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet. 14, 334–336 (1996).

  4. 4

    Broomfield, C.A. & Ford, K.W. Hydrolysis of nerve agents by plasma enzymes. in Cholinesterases (ed Massoulie, J.). 307 (American Chemical Society, Washington, DC, 1991).

  5. 5

    St Clair, M.H. et al. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557–1559 (1991).

  6. 6

    Adkins, S., Can, K.N., Mody, M. & La Du, B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598–608 (1993).

  7. 7

    Humbert, R. et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3, 73–76 (1993).

  8. 8

    Watson, A.D. et al. Protective effect of high density lipoprotein-associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96, 2882–2891 (1995).

  9. 9

    Sorenson, R.C., Primo-Parmo, S.L., Camper, S.A. & La Du, B.N. The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Genomics 30, 431–438 (1995).

  10. 10

    Primo-Parmo, S.L., Sorenson, R.C., Teiber, J. & The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498–507 (1996).

  11. 11

    Ruiz, J.H. et al. The polymorphism (Gln-Argl92) of the high-density lipoprotein-bound enzyme paraoxonase is an independent cardiovascular risk factor in non-insulin-dependent diabetic patients. Lancet 346, 869–872 (1995).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading